PyInvesting

Market research

101140.KO INBIOGEN CO.,Ltd

KO KRW Consumer Cyclical

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
53B
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.83

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

INBIOGEN CO.,Ltd is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.

From a valuation standpoint, the stock is 985.7% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 16.0.

INBIOGEN CO.,Ltd's total revenue sank by 6.4% to $2B since the same quarter in the previous year.

Its net income has dropped by 309.3% to $-32B since the same quarter in the previous year.

Finally, its free cash flow fell by 631.3% to $-4B since the same quarter in the previous year.

Based on the above factors, INBIOGEN CO.,Ltd gets an overall score of 1/5.